Cortisol Augmentation of Prolonged Exposure Therapy
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This study seeks to examine the efficacy of hydrocortisone administration in the augmentation
of the therapeutic effects of Prolonged Exposure (PE) therapy, an empirically tested
treatment shown to be effective in the the treatment of posttraumatic stress disorder (PTSD).
The augmentation builds on both the translation of neuroscience findings demonstrating the
effects of glucocorticoids (GCs) on learning, and on empirical clinical findings from other
investigators demonstrating beneficial effects of GCs in reducing traumatic memories in
trauma-exposed persons.
Phase:
N/A
Details
Lead Sponsor:
VISN 3 Mental Illness Research, Education and Clinical Center